Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine and Sleep Deprivation for Depression
NCT01545843Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Mar 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), sponsored by University of Michigan. Started Mar 2009; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01545843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545843.